Breaking News Instant updates and real-time market news.

FULT

Fulton Financial

$16.07 /

-0.35 (-2.13%)

16:37
03/19/19
03/19
16:37
03/19/19
16:37

Fulton Financial raises quarterly dividend 1c to 13c per share

Fulton Financial said its board of directors has declared a quarterly cash dividend of 13c per share on its common stock, payable on April 15, 2019, to shareholders of record as of April 1, 2019. This is a 1c per share increase from the quarterly cash dividend that was declared on December 18, 2018.

FULT Fulton Financial
$16.07 /

-0.35 (-2.13%)

01/17/19 Piper Sandler
Fulton Financial downgraded to Neutral from Overweight at Piper Jaffray
10/03/18 Barclays
Barclays upgrades Fulton Financial, Webster Financial to Overweight
10/03/18 Barclays
Fulton Financial upgraded to Overweight from Underweight at Barclays
07/19/18 Piper Sandler
Fulton Financial upgraded to Overweight from Neutral at Piper Jaffray

TODAY'S FREE FLY STORIES

Earnings
Smart Sand reports Q4 EPS 5cc, consensus 17c » 06:06
02/26/20
02/26
06:06
02/26/20
06:06
SND

Smart Sand

$1.79 /

-0.085 (-4.55%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
BBVA reinstated with a Neutral at Redburn » 06:06
02/26/20
02/26
06:06
02/26/20
06:06
BBVA

BBVA

$5.07 /

-0.2 (-3.80%)

Redburn reinstated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Banco Santander resinstated with a Buy at Redburn » 06:06
02/26/20
02/26
06:06
02/26/20
06:06
SAN

Banco Santander

$3.72 /

-0.145 (-3.75%)

Redburn reinstated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lowe's sees FY20 adj. EPS $6.45-$6.58, consensus $6.67 » 06:06
02/26/20
02/26
06:06
02/26/20
06:06
LOW

Lowe's

$118.69 /

-4.215 (-3.43%)

Sees FY20 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
United Therapeutics reports Q4 EPS $1.96, consensus $2.65 » 06:05
02/26/20
02/26
06:05
02/26/20
06:05
UTHR

United Therapeutics

$112.96 /

-2.33 (-2.02%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
LivaNova sees FY20 adjusted EPS $3.10-$3.30, consensus $3.30 » 06:04
02/26/20
02/26
06:04
02/26/20
06:04
LIVN

LivaNova

$66.65 /

-2.25 (-3.27%)

Expects FY20 revenues to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Tenet upgraded to Neutral after 26% two-month selloff at JPMorgan » 06:04
02/26/20
02/26
06:04
02/26/20
06:04
THC

Tenet

$29.20 /

-3.49 (-10.68%)

JPMorgan analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
National Vision reports Q4 adj. comparable store sales growth of 8.1%  06:04
02/26/20
02/26
06:04
02/26/20
06:04
EYE

National Vision

$33.82 /

-0.71 (-2.06%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Lowe's reports Q4 adj. EPS 94c, consensus 91c » 06:04
02/26/20
02/26
06:04
02/26/20
06:04
LOW

Lowe's

$118.69 /

-4.215 (-3.43%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
National Vision sees FY20 adjusted EPS 80c-85c, consensus 79c » 06:03
02/26/20
02/26
06:03
02/26/20
06:03
EYE

National Vision

$33.82 /

-0.71 (-2.06%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
LivaNova reports Q4 adjusted EPS $1.00, consensus 98c » 06:02
02/26/20
02/26
06:02
02/26/20
06:02
LIVN

LivaNova

$66.65 /

-2.25 (-3.27%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
CME Group upgraded to Buy from Neutral at UBS » 06:02
02/26/20
02/26
06:02
02/26/20
06:02
CME

CME Group

$208.31 /

-1.12 (-0.53%)

UBS analyst Alex Kramm…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
National Vision reports Q4 adjusted EPS 11c, consensus 1c » 06:01
02/26/20
02/26
06:01
02/26/20
06:01
EYE

National Vision

$33.82 /

-0.71 (-2.06%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Citi upgrades Intercept to Buy on peak sales potential of Ocaliva » 06:00
02/26/20
02/26
06:00
02/26/20
06:00
ICPT

Intercept

$84.52 /

-6.25 (-6.89%)

, CBAY

CymaBay

$1.65 /

-0.045 (-2.65%)

Citi analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Broadridge initiated with a Buy at BTIG » 05:59
02/26/20
02/26
05:59
02/26/20
05:59
BR

Broadridge

$112.48 /

-4.005 (-3.44%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Facebook to ban ads that promise to cure coronavirus, Business Insider reports » 05:59
02/26/20
02/26
05:59
02/26/20
05:59
FB

Facebook

$196.75 /

-4.02 (-2.00%)

Facebook says it will now…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Tesla, Panasonic end joint solar cell production partnership, Nikkei reports » 05:56
02/26/20
02/26
05:56
02/26/20
05:56
TSLA

Tesla

$799.75 /

-34.07 (-4.09%)

, PCRFY

Panasonic

$0.00 /

+ (+0.00%)

Tesla (TSLA) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
VerticalNet initiated with an Outperform at Cowen » 05:56
02/26/20
02/26
05:56
02/26/20
05:56
VERT

VerticalNet

$0.00 /

+ (+0.00%)

Cowen analyst Lance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Amarin shares can rally 20% on litigation win in March, say Citi » 05:56
02/26/20
02/26
05:56
02/26/20
05:56
AMRN

Amarin

$17.54 /

-0.05 (-0.28%)

Citi analyst Joel Beatty…

Citi analyst Joel Beatty maintains a Buy rating on Amarin with a $24 price target following last night's Q4 results. The stock in premarket trading is down 32c to $17.18. The analyst believes Amarin will be successful in its Vascepa patent litigation and sees 20% upside upon the court's decision in March. However, the stock can drop 50% on a negative ruling, Beatty tells investors in a post-earnings research note. In addition, the analyst believes Vascepa sales growth will be strong throughout 2020. The biggest factor impacting Amarin's stock price over the next year is monetizing the European rights to Vascepa, and the implied valuation of the total company from any type of partnership or other transaction that takes place, contends the analyst. He thinks an outright acquisition of Amarin would likely be the best near-term outcome for stockholders. However, if the end of 2020 is reached without some sort of European partnership appearing imminent, it is unlikely the stock price will be much higher at year-end compared to today, contends Beatty.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Resonant to host business news update webinar » 05:55
02/26/20
02/26
05:55
02/26/20
05:55
RESN

Resonant

$1.68 /

-0.08 (-4.55%)

Webinar to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Conference/Events
ConocoPhillips management to meet with JPMorgan » 05:55
02/26/20
02/26
05:55
02/26/20
05:55
COP

ConocoPhillips

$53.83 /

-2.55 (-4.52%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Interface sees FY20 adj. EPS $1.60-$1.70, consensus $1.69 » 05:49
02/26/20
02/26
05:49
02/26/20
05:49
TILE

Interface

$15.70 /

-0.4 (-2.48%)

Sees FY20 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Alcon upgraded to Buy from Hold at Berenberg » 05:49
02/26/20
02/26
05:49
02/26/20
05:49
ALC

Alcon

$58.75 /

-1.755 (-2.90%)

Berenberg analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Interface reports Q4 adj. EPS 46c, consensus 41c » 05:48
02/26/20
02/26
05:48
02/26/20
05:48
TILE

Interface

$15.70 /

-0.4 (-2.48%)

Reports Q4 revenue $339M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Samsonite International upgraded to Buy from Hold at Jefferies » 05:47
02/26/20
02/26
05:47
02/26/20
05:47
SMSEY

Samsonite International

$0.00 /

+ (+0.00%)

Jefferies analyst Anne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.